Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy

Journal of Otolaryngology - Head and Neck Surgery

Volumn 44, Issue 1, 2015, Pages

  Kerr, Paul ^a   Myers, Candace L ^b   Butler, James ^a,b   Alessa, Mohamed ^b   Lambert, Pascal ^b   Cooke, Andrew L ^a,b  

^a Department of Otolaryngology ^*  (Canada)

^b CANCERCARE MANITOBA   (Canada)

Author keywords

Functional outcomes; Intensity modulated; Oropharyngeal

Indexed keywords

CETUXIMAB; CISPLATIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FUNCTIONAL STATUS; FUNCTIONAL STATUS ASSESSMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PERFORMANCE STATUS SCALE FOR HEAD AND NECK; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROYAL BRISBANE HOSPITAL OUTCOME MEASURE FOR SWALLOWING; SELF RATED XEROSTOMIA SCALE; SOFT PALATE; TONGUE; TONSIL; TREATMENT OUTCOME; VOICE HANDICAP INDEX 10; AGED; CARCINOMA, SQUAMOUS CELL; CONFORMAL RADIOTHERAPY; DEGLUTITION DISORDERS; HISTORY; MORTALITY; MULTIMODALITY CANCER THERAPY; OROPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; RADIATION INJURIES; SURVIVAL RATE; VOICE DISORDERS; XEROSTOMIA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; FEMALE; HISTORY, ANCIENT; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; TREATMENT OUTCOME; VOICE DISORDERS; XEROSTOMIA;

EID: 84942594257     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.1186/s40463-015-0068-4     Document Type: Article

References (26)

1. Starmer HM, Tippett D, Webster K, Quon H, Jones B, Hardy S, et al. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ preservation treatment. Head Neck. 2014;36(10):1392-7.
2. Saba NF, Edelman S, Tighiouart M, Gaultney J, Davis LW, Khuri FR, et al. Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head Neck. 2009;31(11):1447-55.
3. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006;24(17):2618-23.
4. Vergeer MR, Doornaert PA, Rietveld D, Leemans CR, Slotman B, Langendijk J, et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys. 2009;74(1):1-8.
5. Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol. 2011;6:1.
6. Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 2012;104(3):343-8.
7. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127-36.
8. Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncol. 2013;49(6):634-42.
9. Lohia S, Rajapurkar M, Nguyen SA, Sharma AK, Gillespie MB, Day TA, et al. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(4):331-7.
10. Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67(5):1309-17.
11. Huang TL, Tsai WL, Chien CY, Lee TF, Fang FM. Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy. Qual Life Res. 2010;19(9):1243-54.
12. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev. 2011;37(7):511-9.
13. McBride SM, Parambi RJ, Jang JW, Goldsmith T, Busse PM, Chan AW, et al. Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes. Head Neck. 2014;36(4):492-8.
14. Myers C, Kerr P, Cooke AW, Bammeke F, Butler J, Lambert P. Functional outcomes after treatment of advanced oropharyngeal carcinoma with radiation or chemoradiation. J Otolaryngol Head Neck Surg. 2012;41(2):108-18.
15. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale, An examination of its reliability and validity in a research setting. Cancer. 1984;53(9):2002-7.
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-55.
17. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer. 1990;66(3):564-9.
18. List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer. 1996;77(11):2294-301.
19. Ward EC, Conroy A-L. Validity, Reliability and Responsivity of the Royal Brisbane Hospital Outcomes Measure for Swallowing. Asia Pacific J Speech Language Hearing. 1999;4:109-29.
20. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the voice handicap index-10. Laryngoscope. 2004;114(9):1549-56.
21. Richardson LA, Jones GW. A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol. 2009;16(1):55.
22. Curran D, Bacchi M, Schmitz SF, Molenberghs G, Sylvester RJ. Identifying the types of missingness in quality of life data from clinical trials. Stat Med. 1998;17(5-7):739-56.
23. Royston P. Multiple imputations of missing values; further update with ICE, with an emphasis on interval censoring. Stat J. 2007;4:445-64.
24. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3):206-13.
25. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J, et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27(12):1992-8.
26. Eisbruch A, Schwartz C, Vineberg K, Damen E, Van As CJ, Marsh R, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425-39.